Jakob Benedict Seidelin

Jakob Benedict Seidelin

Clinical Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology

ORCID: 0000-0003-3230-7966

Publication year:
All
31 - 40 out of 115Page size: 10
  1. 2022
  2. Published

    Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis

    Attauabi, M., Madsen, G. R., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2022, In: Digestive and Liver Disease. 54, 9, p. 1168-1178

    Research output: Contribution to journal › Review › Research › peer-review

  3. 2021
  4. Published

    Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'

    Attauabi, M., Seidelin, Jakob Benedict & Burisch, J., 22 Jun 2021, In: Journal of Crohn's & colitis. 15, 6, p. 1080 1 p.

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  5. Published

    Coronavirus disease 2019, immune-mediated inflammatory diseases and immunosuppressive therapies – A Danish population-based cohort study

    Attauabi, M., Seidelin, Jakob Benedict, Felding, O. K., Wewer, M. D., Vinther Arp, L. K., Sarikaya, M. Z., Egeberg, A., Vladimirova, N., Bendtsen, Flemming & Burisch, J., Mar 2021, In: Journal of Autoimmunity. 118, 102613.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Acute Experimental Barrier Injury Triggers Ulcerative Colitis–Specific Innate Hyperresponsiveness and Ulcerative Colitis–Type Microbiome Changes in Humans

    Seidelin, Jakob Benedict, Bahl, M. I., Licht, T. R., Mead, B. E., Karp, J. M., Johansen, Jens Vilstrup, Riis, Lene Buhl, Ramírez Galera, Marina, Woetmann, Anders & Bjerrum, Jakob Tveiten , 2021, In: Cellular and Molecular Gastroenterology and Hepatology. 12, 4, p. 1281-1296

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19: an artefactual result of research methodology?

    Attauabi, M. & Danish COVID-IBD Study Group, D. C. S. G., 2021, In: Gut. 70, 10, p. 2020-2022

    Research output: Contribution to journal › Letter › Research › peer-review

  8. Published

    CDX2 regulates interleukin-33 gene expression in intestinal epithelial cells (LS174T)

    Larsen, S., Seidelin, Jakob Benedict, Davidsen, J., Dahlgaard, K., Nielsen, Claus Henrik, Bennett, Eric Paul, Pedersen, O. B., Coskun, M. & Troelsen, J. T., 2021, In: FEBS Open Bio. 11, 6, p. 1638-1644

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Effectiveness of third-class biologic treatment in crohn’s disease: A multi-center retrospective cohort study

    Albshesh, A., Taylor, J., Savarino, E. V., Truyens, M., Armuzzi, A., Ribaldone, D. G., Shitrit, A. B. G., Fibelman, M., Molander, P., Liefferinckx, C., Nancey, S., Korani, M., Rutka, M., Acosta, M. B. D., Domislovic, V., Suris, G., Eriksson, C., Alves, C., Mpitouli, A., Di Jiang, C. & 26 others, Tepeš, K., Coletta, M., Foteinogiannopoulou, K., Gisbert, J. P., Amir-Barak, H., Attauabi, M., Seidelin, Jakob Benedict, Afif, W., Marinelli, C., Lobaton, T., Pugliese, D., Maharshak, N., Cremer, A., Limdi, J. K., Molnár, T., Otero-Alvarin, B., Krznaric, Z., Magro, F., Karmiris, K., Raine, T., Drobne, D., Koutroubakis, I., Chaparro, M., Yanai, H., Burisch, J. & Kopylov, U., 2021, In: Journal of Clinical Medicine. 10, 13, 2914.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Efficacy of Ustekinumab for Active Perianal Fistulizing Crohn Disease: A Double-Center Cohort Study

    Attauabi, M., Burisch, J. & Seidelin, Jakob Benedict, 2021, In: Inflammatory Bowel Diseases. 27, 3, p. e37-e38

    Research output: Contribution to journal › Comment/debate › Research › peer-review

  11. Published

    Efficacy of ustekinumab for active perianal fistulizing Crohn’s disease: a systematic review and meta-analysis of the current literature

    Attauabi, M., Burisch, J. & Seidelin, Jakob Benedict, 2021, In: Scandinavian Journal of Gastroenterology. 56, 1, p. 53-58 6 p.

    Research output: Contribution to journal › Review › Research › peer-review

  12. Published

    IBD metabonomics predicts phenotype, disease course, and treatment response

    Bjerrum, Jakob Tveiten , Wang, Y. L., Seidelin, Jakob Benedict & Nielsen, Ole Haagen, 2021, In: EBioMedicine. 71, 103551.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...12 Next

ID: 33971112